A detailed history of Sei Investments CO transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Sei Investments CO holds 15,425 shares of ADPT stock, worth $97,023. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,425
Previous 15,356 0.45%
Holding current value
$97,023
Previous $55,000 41.82%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$3.37 - $5.12 $232 - $353
69 Added 0.45%
15,425 $78,000
Q2 2024

Aug 13, 2024

SELL
$2.34 - $3.96 $115,738 - $195,865
-49,461 Reduced 76.31%
15,356 $55,000
Q1 2024

May 07, 2024

BUY
$2.88 - $4.8 $106 - $177
37 Added 0.06%
64,817 $208,000
Q4 2023

Feb 14, 2024

BUY
$3.46 - $5.33 $761 - $1,172
220 Added 0.34%
64,780 $317,000
Q3 2023

Nov 14, 2023

BUY
$5.07 - $8.44 $102,170 - $170,082
20,152 Added 45.38%
64,560 $351,000
Q2 2023

Aug 11, 2023

SELL
$6.19 - $8.78 $15,184 - $21,537
-2,453 Reduced 5.23%
44,408 $297,000
Q1 2023

May 12, 2023

BUY
$7.8 - $10.11 $199,609 - $258,725
25,591 Added 120.31%
46,861 $413,000
Q4 2022

Feb 10, 2023

BUY
$6.26 - $9.34 $13,008 - $19,408
2,078 Added 10.83%
21,270 $162,000
Q3 2022

Nov 14, 2022

SELL
$6.5 - $12.67 $14,449 - $28,165
-2,223 Reduced 10.38%
19,192 $137,000
Q2 2022

Aug 15, 2022

SELL
$6.4 - $14.73 $308,691 - $710,472
-48,233 Reduced 69.25%
21,415 $173,000
Q1 2022

May 13, 2022

BUY
$10.12 - $28.9 $6,486 - $18,524
641 Added 0.93%
69,648 $967,000
Q4 2021

Feb 14, 2022

BUY
$25.17 - $36.85 $110,647 - $161,992
4,396 Added 6.8%
69,007 $1.94 Million
Q3 2021

Nov 12, 2021

SELL
$30.02 - $39.87 $56,257 - $74,716
-1,874 Reduced 2.82%
64,611 $2.2 Million
Q2 2021

Aug 06, 2021

SELL
$32.22 - $44.59 $586,081 - $811,092
-18,190 Reduced 21.48%
66,485 $2.72 Million
Q1 2021

May 12, 2021

SELL
$37.26 - $67.74 $1.87 Million - $3.41 Million
-50,272 Reduced 37.25%
84,675 $3.8 Million
Q4 2020

Feb 08, 2021

BUY
$45.01 - $65.47 $684,872 - $996,191
15,216 Added 12.71%
134,947 $7.96 Million
Q3 2020

Dec 04, 2020

SELL
$35.79 - $48.81 $466,272 - $635,896
-13,028 Reduced 9.81%
119,731 $5.83 Million
Q3 2020

Nov 06, 2020

BUY
$35.79 - $48.81 $678,900 - $925,876
18,969 Added 16.67%
132,759 $6.47 Million
Q2 2020

Aug 17, 2020

BUY
$24.95 - $48.38 $1.43 Million - $2.77 Million
57,305 Added 101.45%
113,790 $5.51 Million
Q2 2020

Aug 11, 2020

SELL
$24.95 - $48.38 $1.56 Million - $3.02 Million
-62,477 Reduced 52.52%
56,485 $1.7 Million
Q1 2020

May 14, 2020

BUY
$16.96 - $34.16 $1.07 Million - $2.15 Million
62,815 Added 111.88%
118,962 $3.31 Million
Q4 2019

Feb 06, 2020

BUY
$24.56 - $32.8 $679,010 - $906,821
27,647 Added 97.01%
56,147 $1.68 Million
Q3 2019

Nov 12, 2019

BUY
$30.31 - $53.51 $399,758 - $705,743
13,189 Added 86.14%
28,500 $881,000
Q2 2019

Aug 14, 2019

BUY
$40.3 - $48.3 $617,033 - $739,521
15,311 New
15,311 $740,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $899M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.